Lang Li

999 total citations
21 papers, 720 citations indexed

About

Lang Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lang Li has authored 21 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Lang Li's work include Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Circular RNAs in diseases (4 papers). Lang Li is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Circular RNAs in diseases (4 papers). Lang Li collaborates with scholars based in China, United States and Thailand. Lang Li's co-authors include Christopher J. Sweeney, Kenneth P. Nephew, Alfred S.L. Cheng, Qianqian Zhao, Cori Hartman-Frey, Zeruesenay Desta, James M. Rae, Todd C. Skaar, Meiyun Fan and David A. Flockhart and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Lang Li

18 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lang Li China 12 389 222 188 173 108 21 720
Kwi Hye Koh United States 16 320 0.8× 137 0.6× 253 1.3× 75 0.4× 54 0.5× 21 810
Mitul Shah United Kingdom 16 389 1.0× 191 0.9× 337 1.8× 286 1.7× 93 0.9× 22 967
Patrick H. Rooney United Kingdom 16 512 1.3× 248 1.1× 292 1.6× 124 0.7× 103 1.0× 21 980
Kurt W. Fisher United States 18 423 1.1× 160 0.7× 248 1.3× 43 0.2× 97 0.9× 44 839
Magdalena Niemira Poland 17 459 1.2× 271 1.2× 121 0.6× 61 0.4× 122 1.1× 47 828
Yongdong Niu China 16 414 1.1× 159 0.7× 222 1.2× 52 0.3× 93 0.9× 43 890
Valérie Le Morvan France 18 389 1.0× 129 0.6× 310 1.6× 74 0.4× 113 1.0× 45 745
Junichi Hisatake Japan 11 424 1.1× 149 0.7× 119 0.6× 124 0.7× 60 0.6× 21 784
Maria Teresa Landi United States 9 293 0.8× 100 0.5× 241 1.3× 66 0.4× 75 0.7× 18 604
Norman Pratt United Kingdom 11 284 0.7× 178 0.8× 516 2.7× 107 0.6× 200 1.9× 14 958

Countries citing papers authored by Lang Li

Since Specialization
Citations

This map shows the geographic impact of Lang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lang Li more than expected).

Fields of papers citing papers by Lang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lang Li. The network helps show where Lang Li may publish in the future.

Co-authorship network of co-authors of Lang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lang Li. A scholar is included among the top collaborators of Lang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lang Li. Lang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tan, Li, Xuemei Bai, Li Deng, et al.. (2025). Prevalence, associated factors, and short-term impact of central sensitization in high-altitude patients undergoing total knee arthroplasty. International Orthopaedics. 49(8). 1887–1894.
3.
Li, Lang, et al.. (2023). Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer. Journal Of Big Data. 10(1). 1 indexed citations
4.
Owen, Dwight H., Regan M. Memmott, Gregory A. Otterson, et al.. (2023). Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.. Journal of Clinical Oncology. 41(16_suppl). 2626–2626. 1 indexed citations
5.
Li, Lang, et al.. (2022). Construction of a four-mRNA prognostic signature with its ceRNA network in CESC. Scientific Reports. 12(1). 10691–10691. 7 indexed citations
8.
Zhang, Shijun, Chien‐Wei Chiang, Gregory A. Otterson, et al.. (2021). Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events. Cancer Immunology Immunotherapy. 70(10). 2761–2769. 10 indexed citations
9.
Ding, Wei, Zheng Huang, Gaofeng Zhou, et al.. (2021). Diffusion-weighted imaging for predicting tumor consistency and extent of resection in patients with pituitary adenoma. Neurosurgical Review. 44(5). 2933–2941. 17 indexed citations
10.
Li, Lang, et al.. (2020). Biological roles of Yin Yang 2: Its implications in physiological and pathological events. Journal of Cellular and Molecular Medicine. 24(22). 12886–12899. 14 indexed citations
11.
Spakowicz, Daniel, Rebecca Hoyd, Marium Husain, et al.. (2020). Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications. BMC Cancer. 20(1). 383–383. 45 indexed citations
12.
Chen, Yunping, Lang Li, Feng Gao, et al.. (2020). Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 15 (SNHG15) Alleviates Osteoarthritis Progression by Regulation of Extracellular Matrix Homeostasis. Medical Science Monitor. 26. e923868–e923868. 18 indexed citations
13.
Li, Yanjun, Vivi Kasim, Lang Li, et al.. (2019). Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation. Theranostics. 9(25). 7599–7615. 57 indexed citations
14.
Su, Qiang, Xiangwei Lv, Yuhan Sun, et al.. (2018). Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury. Biomedicine & Pharmacotherapy. 105. 1164–1171. 19 indexed citations
16.
Humphreys, Tricia L., Lang Li, Xiaoman Li, et al.. (2007). Dysregulated Immune Profiles for Skin and Dendritic Cells Are Associated with Increased Host Susceptibility toHaemophilus ducreyiInfection in Human Volunteers. Infection and Immunity. 75(12). 5686–5697. 21 indexed citations
17.
Fan, Meiyun, Pearlly S. Yan, Cori Hartman-Frey, et al.. (2006). Diverse Gene Expression and DNA Methylation Profiles Correlate with Differential Adaptation of Breast Cancer Cells to the Antiestrogens Tamoxifen and Fulvestrant. Cancer Research. 66(24). 11954–11966. 194 indexed citations
18.
Li, Lang, Zeruesenay Desta, Qianqian Zhao, et al.. (2006). Endoxifen, a Secondary Metabolite of Tamoxifen, and 4-OH-Tamoxifen Induce Similar Changes in Global Gene Expression Patterns in MCF-7 Breast Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 318(2). 503–512. 111 indexed citations
19.
Hahn, Noah M., Sharon Marsh, William B. Fisher, et al.. (2006). Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis. Clinical Cancer Research. 12(20). 6094–6099. 48 indexed citations
20.
Sweeney, Christopher J., Lang Li, Rajasubramaniam Shanmugam, et al.. (2004). Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate. Clinical Cancer Research. 10(16). 5501–5507. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026